Search research articles
Contact Us
Filters
Showing results (91-100 of 108) with videos related to
Page
of 11
Sort By:
Molecular Immunology
|
April 22, 2014
Divergent roles of histone deacetylase 6 (HDAC6) and histone deacetylase 11 (HDAC11) on the transcriptional regulation of IL10 in antigen presenting cells
Fengdong Cheng, Maritza Lienlaf, Patricio Perez-Villarroel, et al.
Cell Reports
|
June 14, 2016
MOF Acetylates the Histone Demethylase LSD1 to Suppress Epithelial-to-Mesenchymal Transition
Huacheng Luo, Anitha K Shenoy, Xuehui Li, et al.
Nature Microbiology
|
July 15, 2020
Lactate production by Staphylococcus aureus biofilm inhibits HDAC11 to reprogramme the host immune response during persistent infection
Cortney E Heim, Megan E Bosch, Kelsey J Yamada, et al.
Cancer Research
|
February 12, 2025
Stabilization of RUNX1 Induced by O-GlcNAcylation Promotes PDGF-BB-Mediated Resistance to CDK4/6 Inhibitors in Breast Cancer
Shuyan Zhou, Yi Zhang, Julie Belmar, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 12, 2022
Reversible lysine fatty acylation of an anchoring protein mediates adipocyte adrenergic signaling
Rushita A Bagchi, Emma L Robinson, Tianjing Hu, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 16, 2024
Expression of Concern: A Novel Role for Histone Deacetylase 6 in the Regulation of the Tolerogenic STAT3/IL-10 Pathway in APCs
Fengdong Cheng, Maritza Lienlaf, Hong-Wei Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 10, 2014
A novel role for histone deacetylase 6 in the regulation of the tolerogenic STAT3/IL-10 pathway in APCs
Fengdong Cheng, Maritza Lienlaf, Hong-Wei Wang, et al.
Cancer Research
|
April 17, 2019
HDAC8 Regulates a Stress Response Pathway in Melanoma to Mediate Escape from BRAF Inhibitor Therapy
Michael F Emmons, Fernanda Faião-Flores, Ritin Sharma, et al.
Cancer Cell
|
June 13, 2023
Retraction Notice to: Coordinated Silencing of MYC-Mediated miR-29 by HDAC3 and EZH2 as a Therapeutic Target of Histone Modification in Aggressive B-Cell Lymphomas
Xinwei Zhang, Xiaohong Zhao, Warren Fiskus, et al.
Cancer Cell
|
October 20, 2012
Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas
Xinwei Zhang, Xiaohong Zhao, Warren Fiskus, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 108) with videos related to
Sort By:
Page
of 11
Molecular Immunology
|
April 22, 2014
Divergent roles of histone deacetylase 6 (HDAC6) and histone deacetylase 11 (HDAC11) on the transcriptional regulation of IL10 in antigen presenting cells
Fengdong Cheng, Maritza Lienlaf, Patricio Perez-Villarroel, et al.
Cell Reports
|
June 14, 2016
MOF Acetylates the Histone Demethylase LSD1 to Suppress Epithelial-to-Mesenchymal Transition
Huacheng Luo, Anitha K Shenoy, Xuehui Li, et al.
Nature Microbiology
|
July 15, 2020
Lactate production by Staphylococcus aureus biofilm inhibits HDAC11 to reprogramme the host immune response during persistent infection
Cortney E Heim, Megan E Bosch, Kelsey J Yamada, et al.
Cancer Research
|
February 12, 2025
Stabilization of RUNX1 Induced by O-GlcNAcylation Promotes PDGF-BB-Mediated Resistance to CDK4/6 Inhibitors in Breast Cancer
Shuyan Zhou, Yi Zhang, Julie Belmar, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 12, 2022
Reversible lysine fatty acylation of an anchoring protein mediates adipocyte adrenergic signaling
Rushita A Bagchi, Emma L Robinson, Tianjing Hu, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 16, 2024
Expression of Concern: A Novel Role for Histone Deacetylase 6 in the Regulation of the Tolerogenic STAT3/IL-10 Pathway in APCs
Fengdong Cheng, Maritza Lienlaf, Hong-Wei Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 10, 2014
A novel role for histone deacetylase 6 in the regulation of the tolerogenic STAT3/IL-10 pathway in APCs
Fengdong Cheng, Maritza Lienlaf, Hong-Wei Wang, et al.
Cancer Research
|
April 17, 2019
HDAC8 Regulates a Stress Response Pathway in Melanoma to Mediate Escape from BRAF Inhibitor Therapy
Michael F Emmons, Fernanda Faião-Flores, Ritin Sharma, et al.
Cancer Cell
|
June 13, 2023
Retraction Notice to: Coordinated Silencing of MYC-Mediated miR-29 by HDAC3 and EZH2 as a Therapeutic Target of Histone Modification in Aggressive B-Cell Lymphomas
Xinwei Zhang, Xiaohong Zhao, Warren Fiskus, et al.
Cancer Cell
|
October 20, 2012
Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas
Xinwei Zhang, Xiaohong Zhao, Warren Fiskus, et al.
Page
of 11